Results 101 to 110 of about 42,003 (148)

Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review. [PDF]

PLoS One
Arzayus-Patiño L, Hinojosa-Angulo AY, Rodríguez-Angulo KA, Sánchez-Caicedo MA, Benavides-Córdoba V.   +4 more
europepmc   +1 more source

Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study. [PDF]

BMJ Open
Senanayake S, Lee ASY, Graves N, Win PPS, Lee A, Lau YH, Hausenloy DJ, Yeo KK, Chan MY, Wong RCC, Loh SY, Sim KLD, Chow W, Tan KB, Kularatna S.   +14 more
europepmc   +1 more source

Beta adrenergic signaling as a therapeutic target for autoimmunity. [PDF]

J Neuroimmunol
Lauten TH, Reed EC, Natour T, Pitts LJ, Jojo CN, Griffin BL, Case AJ.   +6 more
europepmc   +1 more source

Chronic stress-related neuroendocrine mediators and ovarian cancer. [PDF]

Discov Oncol
Du H, Yu G, Hu R, Du J, Liu C.
europepmc   +1 more source

Prolonged alpha-blockade and doxazosin are associated with hypertensive crisis in pheochromocytoma surgery. [PDF]

Front Endocrinol (Lausanne)
Zawadzka K, Pisarska-Adamczyk M, Hubalewska-Dydejczyk A, Pędziwiatr M.   +3 more
europepmc   +1 more source

Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications. [PDF]

Int J Mol Sci
Nasoufidou A, Bantidos MG, Fyntanidou B, Kofos C, Stachteas P, Arvanitaki A, Karakasis P, Sagris M, Kassimis G, Fragakis N, Karagiannidis E.   +10 more
europepmc   +1 more source

Drug Interactions With Excessive Daytime Sleepiness Treatments. [PDF]

J Pharm Technol
Thomas SV, Malesker MA, Hilleman DE, Dewan NA.   +3 more
europepmc   +1 more source

Antihypertensive Drugs and Dental Caries Risk: A Drug-Target Mendelian Randomization Analysis. [PDF]

Int J Genomics
Shi W, Liu S, Wu X, Cheng W, Jia X, Hu Z.   +5 more
europepmc   +1 more source